• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥地利的宫颈癌筛查

Cervical cancer screening in Austria.

作者信息

Breitenecker G, Wiener H, Stani J

机构信息

Department of Gynecopathology, University of Vienna, Waehringer Guertel 18-20, 6Q, A-1090, Vienna, Austria.

出版信息

Eur J Cancer. 2000 Nov;36(17):2189-90. doi: 10.1016/s0959-8049(00)00322-1.

DOI:10.1016/s0959-8049(00)00322-1
PMID:11072202
Abstract

Austria's target population of women aged 20 years and over consists of 3 million people. There is mainly opportunistic screening, except in one county with a target population of 120000, in which organised screening has been practiced for several years. There are approximately 1.5 million smears annually, exclusively taken by gynaecologists. The recommended screening interval is 1 year. The slides are screened by MTs with a maximum workload of 12000 smears annually in 65 laboratories, mainly headed by pathologists. As shown by Vutuc and colleagues (Wien Klin Wochenschr 1999, 111, 354-359) the opportunistic screening system covers 60% of the Austrian target population leaving an unsatisfactorily high rate of underserved, mainly postmenopausal, women. Nevertheless, the cervical cancer mortality rate could have been decreased to one third during the past 40 years.

摘要

奥地利20岁及以上女性的目标人群有300万人。除了一个目标人群为12万的县开展了数年的组织性筛查外,主要是机会性筛查。每年约有150万份涂片,均由妇科医生采集。推荐的筛查间隔为1年。涂片由医学检验技术员筛查,65个实验室的医学检验技术员年最大工作量为12000份涂片,这些实验室主要由病理学家主管。如武图克及其同事所示(《维也纳临床周报》,1999年,第111期,354 - 359页),机会性筛查系统覆盖了60%的奥地利目标人群,导致未得到充分服务的女性比例高得令人不满意,这些女性主要是绝经后女性。尽管如此,在过去40年里宫颈癌死亡率已降至三分之一。

相似文献

1
Cervical cancer screening in Austria.奥地利的宫颈癌筛查
Eur J Cancer. 2000 Nov;36(17):2189-90. doi: 10.1016/s0959-8049(00)00322-1.
2
Cytopathology in Austria.奥地利的细胞病理学
Cytopathology. 2004 Apr;15(2):113-8. doi: 10.1111/j.1365-2303.2004.00125.x.
3
Cervical cancer screening in Denmark.丹麦的宫颈癌筛查
Eur J Cancer. 2000 Nov;36(17):2198-204. doi: 10.1016/s0959-8049(00)00309-9.
4
[Screening for cervical cancer in the county of Funen. Status of 25 years of development and experiences].[丹麦菲英岛宫颈癌筛查。25年发展现状与经验]
Ugeskr Laeger. 2006 May 29;168(22):2163-6.
5
Cervical cancer screening programme in Finland.芬兰的宫颈癌筛查项目。
Eur J Cancer. 2000 Nov;36(17):2209-14. doi: 10.1016/s0959-8049(00)00311-7.
6
Cervical cancer screening in Spain.
Eur J Cancer. 2000 Nov;36(17):2250-4. doi: 10.1016/s0959-8049(00)00319-1.
7
Cervical cancer screening in England.英格兰的宫颈癌筛查
Eur J Cancer. 2000 Nov;36(17):2205-8. doi: 10.1016/s0959-8049(00)00310-5.
8
Cervical cancer screening in France.法国的宫颈癌筛查
Eur J Cancer. 2000 Nov;36(17):2215-20. doi: 10.1016/s0959-8049(00)00312-9.
9
Cervical cancer screening in Italy.意大利的宫颈癌筛查
Eur J Cancer. 2000 Nov;36(17):2235-9. doi: 10.1016/s0959-8049(00)00316-6.
10
Quality assurance in cervical cancer screening: the Icelandic experience 1964-1993.
Eur J Cancer. 1995;31A(5):728-34. doi: 10.1016/0959-8049(94)00531-9.

引用本文的文献

1
Challenges in the Prevention of Cervical Cancer in Romania.罗马尼亚宫颈癌防治面临的挑战。
Int J Environ Res Public Health. 2021 Feb 10;18(4):1721. doi: 10.3390/ijerph18041721.
2
Quality of screening with conventional Pap smear in Austria - a longitudinal evaluation.奥地利传统巴氏涂片筛查的质量——一项纵向评估。
BMC Public Health. 2013 Oct 23;13:998. doi: 10.1186/1471-2458-13-998.